Bristol-Myers Squibb
Health Care |
Pharmaceutical Companies
New York, NY 10154-0101
Recent News About Bristol-Myers Squibb
-
NEW YORK (Legal Newsline) – Companies facing lawsuits in New York City’s controversial asbestos court are using U.S. Supreme Court decisions from recent years that prevented plaintiffs lawyers from suing in whatever court they felt like.
-
WASHINGTON (Legal Newsline) - Federal district courts are divided on whether a landmark U.S. Supreme Court decision on personal jurisdiction is applicable to class actions.
-
ST. LOUIS - Just before Houston plaintiff attorney Mark Lanier wrapped up opening arguments Wednesday morning on behalf of 77 women claiming asbestos in talcum powder caused ovarian cancer he told jurors about a study of infants who had been born dead.
-
WASHINGTON (Legal Newsline) – Since last year’s U.S. Supreme Court ruling that dealt a blow to forum-shopping personal injury attorneys, companies threatened with sprawling, 50-state litigation have not been forced into defending cases all over the country.
-
While the U.S. Supreme Court's Bristol Myers Squibb ruling has resulted in some big wins for businesses targeted by the plaintiffs' bar, new strategies and theories deployed by plaintiffs' lawyers may be blunting the further impact of that decision, despite high hopes from some it would largely thwart the ability of out-of-state plaintiffs to sue out-of-state defendants in a favorable court forum.
-
New York City law firm Weitz & Luxenberg PC and Bristol-Myers Squibb and Medical Engineering Corporation -- the makers of the implants at issue -- allegedly entered into a stipulated agreement, dismissing the woman’s case with prejudice. The woman claims the agreement was entered into without her knowledge and in direct contradiction to an agreed upon tolling agreement.
